Project Number 1R44AG053150-01 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for TAU OLIGOMER PLATFORM VALIDATION USING LEAD SERIES CANDIDATE IN HTAU MICE Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator MOE, JAMES G Principal Investigator First Name JAMES Principal Investigator Last Name MOE Awardee Organization OLIGOMERIX, INC Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development FY Overall Cost $749,795 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
